JTT-302

· Akros Pharma Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JTT-302, covering 2013-02-04 to 2013-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels [Phase 2]